UAE filling is probably symbolic coz it will probably follow UK
Laduree
Posts (179)
If NVAX is opinionated outside the routine EMA meeting 12/13-12/16, then EMA will call an extraordinary meeting to address jt. ( as they did to PFE/BNTX and MRNA)
Can anyone look up how EMA meetings and approval procedure was on mRNA vaccines last year ? What stage is List of Questions before issuing an opinion ?
If EMA concludes that the benefits of Nuvaxovid outweigh its risks in protecting against COVID‑19, it will recommend granting a conditional marketing authorisation. The European Commission will then fast-track its decision-making process with a view to granting a conditional marketing authorisation valid in all EU and EEA Member States within days.
EMA will communicate at the time of CHMP’s opinion.
How long are the days ??? Over 7 days we call it a week, over 30 days we call it a month.
The England study didn’t report the result about using Pfizer Covid vaccine as mixed booster to other Covid vaccines? Why ? Why ?
https://twitter.com/ema_news/status/1468931664789319684?s=10
#Novavax’s COVID-19 vaccine: We could possibly conclude its evaluation before the end of the year. When authorised, this vaccine will provide a new option for vaccinating people in the EU and globally.
#EMAPresser #COVID19vaccines
EMA and ECDC recommendations on heterologous vaccination courses against COVID-19 Share
News 07/12/2021
‘Mix-and-match’ approach can be used for both initial courses and boosters
Plants in the EU will make 3.6 billion COVID-19 doses in 2022, up from about 3 billion this year, the official said, adding: "This is much more than what we need to vaccinate and give a booster to our population".
The official did not give a breakdown by vaccine makers.
The largest producers in Europe have so far been Pfizer Inc (PFE.N) and BioNTech .
Other vaccine makers with facilities in the EU are AstraZeneca (AZN.L), Moderna (MRNA.O) and Johnson & Johnson (JNJ.N). Novavax (NVAX.O) also has production capacity in the EU and is expected to soon start delivering shots in Europe.
Hold. Day new high is forming
It’s definitely wrong time to short this stock these days! Shorters, cover yourself before margin call and it’s not too late to convert to bull now.